Pricing Log in Create free account

Alector, Inc. (ALEC) vs Eikon Therapeutics, Inc. (EIKN)

Alector, Inc. and Eikon Therapeutics, Inc. are both Biotechnology companies. Alector, Inc. and Eikon Therapeutics, Inc. are of similar size ($316.3M and $309.9M). Eikon Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Alector, Inc. trades at 6.6×. Alector, Inc. has the higher net margin (23.9% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Alector, Inc. leads on 7 and Eikon Therapeutics, Inc. on 4.

Valuation

Metric ALEC EIKN Biotechnology median
P/E 6.57 n/m 10.60
P/S 1.49 n/m 9.40
P/B 2.22 0.69 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.62 0.66
EV/Sales 0.80 n/m 9.02
Earnings yield 15.22% (1,147.55%) (32.88%)
Free cash flow yield (58.00%) (138.83%) (23.13%)

Profitability

Metric ALEC EIKN Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin 20.16% 0.00% 0.00%
Net margin 23.87% 0.00% 0.00%
Free cash flow margin (86.40%) 0.00% 0.00%
Return on equity 47.52% 0.00% (51.96%)
Return on assets 16.53% (90.08%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALEC EIKN Biotechnology median
Revenue growth (TTM) 151.23% — 6.76%
EPS growth (last fiscal year) (13.01%) (19.15%) 29.88%
Revenue growth, 5-year CAGR (0.05%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ALEC EIKN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.10 9.89 4.97
Net debt to EBITDA 1.61 1.07 1.01

Dividend

Metric ALEC EIKN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ALEC EIKN Biotechnology median
Market cap 309.86m 316.32m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack